LCP
Legacy Capital Partners’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-5,525
| Closed | -$272K | – | 131 |
|
|
2018
Q1 | $272K | Hold |
5,525
| – | – | 0.14% | 108 |
|
|
2017
Q4 | $297K | Sell |
5,525
-400
| -7% | -$21.5K | 0.15% | 101 |
|
|
2017
Q3 | $285K | Buy |
5,925
+1,000
| +20% | +$48.1K | 0.15% | 100 |
|
|
2017
Q2 | $211K | Buy |
+4,925
| New | +$211K | 0.11% | 109 |
|
|
2016
Q4 | – | Sell |
-7,290
| Closed | -$304K | – | 113 |
|
|
2016
Q3 | $304K | Buy |
7,290
+100
| +1% | +$4.17K | 0.19% | 98 |
|
|
2016
Q2 | $387K | Sell |
7,190
-70
| -1% | -$3.77K | 0.24% | 91 |
|
|
2016
Q1 | $394K | Sell |
7,260
-50
| -0.7% | -$2.71K | 0.25% | 86 |
|
|
2015
Q4 | $425K | Sell |
7,310
-100
| -1% | -$5.81K | 0.27% | 80 |
|
|
2015
Q3 | $402K | Hold |
7,410
| – | – | 0.27% | 82 |
|
|
2015
Q2 | $406K | Sell |
7,410
-300
| -4% | -$16.4K | 0.26% | 86 |
|
|
2015
Q1 | $412K | Buy |
7,710
+410
| +6% | +$21.9K | 0.26% | 82 |
|
|
2014
Q4 | $309K | Buy |
7,300
+580
| +9% | +$24.6K | 0.2% | 93 |
|
|
2014
Q3 | $321K | Sell |
6,720
-1,600
| -19% | -$76.4K | 0.21% | 85 |
|
|
2014
Q2 | $385K | Sell |
8,320
-800
| -9% | -$37K | 0.25% | 80 |
|
|
2014
Q1 | $417K | Buy |
9,120
+7,066
| +344% | +$323K | 0.3% | 73 |
|
|
2013
Q4 | $380K | Sell |
2,054
-1,200
| -37% | -$222K | 0.27% | 77 |
|
|
2013
Q3 | $551K | Buy |
3,254
+195
| +6% | +$33K | 0.41% | 66 |
|
|
2013
Q2 | $475K | Buy |
+3,059
| New | +$475K | 0.36% | 69 |
|